nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—atopic dermatitis	0.631	1	CbGaD
Maraviroc—CYP3A4—Pimecrolimus—atopic dermatitis	0.0405	0.258	CbGbCtD
Maraviroc—CYP3A4—Tacrolimus—atopic dermatitis	0.0241	0.153	CbGbCtD
Maraviroc—CYP3A4—Loratadine—atopic dermatitis	0.0176	0.112	CbGbCtD
Maraviroc—CYP3A4—Methylprednisolone—atopic dermatitis	0.0161	0.103	CbGbCtD
Maraviroc—CYP3A4—Triamcinolone—atopic dermatitis	0.0122	0.0778	CbGbCtD
Maraviroc—CYP3A4—Betamethasone—atopic dermatitis	0.0105	0.0667	CbGbCtD
Maraviroc—CYP3A4—Prednisolone—atopic dermatitis	0.0103	0.0659	CbGbCtD
Maraviroc—CYP3A4—Hydrocortisone—atopic dermatitis	0.0098	0.0624	CbGbCtD
Maraviroc—CYP3A4—Prednisone—atopic dermatitis	0.00976	0.0622	CbGbCtD
Maraviroc—CYP3A4—Dexamethasone—atopic dermatitis	0.00609	0.0388	CbGbCtD
Maraviroc—CCR5—IL12-mediated signaling events—IL18R1—atopic dermatitis	0.00571	0.0712	CbGpPWpGaD
Maraviroc—CCR5—Binding and entry of HIV virion—CD4—atopic dermatitis	0.00517	0.0645	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—RELB—atopic dermatitis	0.00432	0.054	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL22—atopic dermatitis	0.00346	0.0432	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL27—atopic dermatitis	0.00309	0.0385	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL17—atopic dermatitis	0.00277	0.0346	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL11—atopic dermatitis	0.00223	0.0279	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—STAT6—atopic dermatitis	0.00199	0.0248	CbGpPWpGaD
Maraviroc—CCR5—Early Phase of HIV Life Cycle—CD4—atopic dermatitis	0.0019	0.0237	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCR3—atopic dermatitis	0.00182	0.0227	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCR3—atopic dermatitis	0.00159	0.0199	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—CCR3—atopic dermatitis	0.00146	0.0182	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CARD11—atopic dermatitis	0.0014	0.0174	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.0013	0.0163	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL10—atopic dermatitis	0.00129	0.016	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—CXCR3—atopic dermatitis	0.00127	0.0159	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00116	0.0145	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL17A—atopic dermatitis	0.00111	0.0138	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL5—atopic dermatitis	0.00111	0.0138	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—CXCR3—atopic dermatitis	0.00108	0.0135	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL18—atopic dermatitis	0.00105	0.0131	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00104	0.013	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD8A—atopic dermatitis	0.00103	0.0129	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL4—atopic dermatitis	0.00101	0.0127	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00098	0.0122	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000874	0.0109	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00084	0.0105	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000779	0.00973	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD8A—atopic dermatitis	0.000746	0.00931	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000699	0.00872	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000685	0.00855	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL22—atopic dermatitis	0.000666	0.00831	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IFNG—atopic dermatitis	0.000613	0.00766	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00061	0.00762	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00061	0.00762	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL8—atopic dermatitis	0.000603	0.00752	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000598	0.00747	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL27—atopic dermatitis	0.000593	0.00741	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD4—atopic dermatitis	0.000592	0.00739	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000578	0.00722	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000578	0.00721	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000563	0.00703	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL1B—atopic dermatitis	0.000547	0.00683	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL2—atopic dermatitis	0.000545	0.0068	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000536	0.00669	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL17—atopic dermatitis	0.000532	0.00664	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000505	0.0063	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000484	0.00604	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000468	0.00585	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000459	0.00573	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL11—atopic dermatitis	0.000429	0.00535	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD4—atopic dermatitis	0.000428	0.00535	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000416	0.0052	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000409	0.00511	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000409	0.00511	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000408	0.00509	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000401	0.00501	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000396	0.00494	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000363	0.00453	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000351	0.00438	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCR3—atopic dermatitis	0.00035	0.00437	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL22—atopic dermatitis	0.000342	0.00426	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCL27—atopic dermatitis	0.000335	0.00419	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000324	0.00405	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—NPS—atopic dermatitis	0.000312	0.00389	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—TAC1—atopic dermatitis	0.000312	0.00389	CbGpPWpGaD
Maraviroc—CCR5—HIV Life Cycle—CD4—atopic dermatitis	0.000308	0.00384	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCR3—atopic dermatitis	0.000306	0.00382	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL27—atopic dermatitis	0.000304	0.0038	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000279	0.00349	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL17—atopic dermatitis	0.000273	0.00341	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL10—atopic dermatitis	0.000247	0.00308	CbGpPWpGaD
Maraviroc—CCR5—Disease—GLB1—atopic dermatitis	0.000245	0.00306	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—atopic dermatitis	0.000232	0.00289	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000227	0.00283	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL11—atopic dermatitis	0.00022	0.00275	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FCER2—atopic dermatitis	0.000217	0.00271	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL5—atopic dermatitis	0.000213	0.00265	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—CD4—atopic dermatitis	0.000213	0.00265	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL22—atopic dermatitis	0.000202	0.00252	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCR3—atopic dermatitis	0.000198	0.00247	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000191	0.00239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL27—atopic dermatitis	0.00018	0.00225	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCR3—atopic dermatitis	0.000179	0.00224	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NPS—atopic dermatitis	0.000176	0.0022	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TAC1—atopic dermatitis	0.000176	0.0022	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000173	0.00216	CbGpPWpGaD
Maraviroc—CCR5—Disease—SLC11A1—atopic dermatitis	0.000164	0.00205	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL5—atopic dermatitis	0.000164	0.00204	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL17—atopic dermatitis	0.000161	0.00201	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPS—atopic dermatitis	0.00016	0.002	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TAC1—atopic dermatitis	0.00016	0.002	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCR3—atopic dermatitis	0.000157	0.00196	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000152	0.0019	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL5—atopic dermatitis	0.000149	0.00186	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KIF3A—atopic dermatitis	0.000144	0.0018	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00014	0.00174	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CMA1—atopic dermatitis	0.00013	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL11—atopic dermatitis	0.00013	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL10—atopic dermatitis	0.000127	0.00158	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STAT6—atopic dermatitis	0.000122	0.00153	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCL5—atopic dermatitis	0.00012	0.0015	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL8—atopic dermatitis	0.000116	0.00145	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL5—atopic dermatitis	0.000109	0.00136	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000106	0.00133	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR3—atopic dermatitis	0.000106	0.00132	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TAC1—atopic dermatitis	9.45e-05	0.00118	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPS—atopic dermatitis	9.45e-05	0.00118	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCR3—atopic dermatitis	9.27e-05	0.00116	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL5—atopic dermatitis	8.78e-05	0.0011	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL10—atopic dermatitis	7.49e-05	0.000935	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—atopic dermatitis	6.55e-05	0.000817	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL5—atopic dermatitis	6.45e-05	0.000805	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2—atopic dermatitis	6.26e-05	0.000781	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Tacrolimus—atopic dermatitis	6.19e-05	0.000469	CcSEcCtD
Maraviroc—Conjunctivitis—Dexamethasone—atopic dermatitis	6.15e-05	0.000466	CcSEcCtD
Maraviroc—Conjunctivitis—Betamethasone—atopic dermatitis	6.15e-05	0.000466	CcSEcCtD
Maraviroc—Connective tissue disorder—Methylprednisolone—atopic dermatitis	6.14e-05	0.000465	CcSEcCtD
Maraviroc—Pancreatitis—Prednisone—atopic dermatitis	6.06e-05	0.000459	CcSEcCtD
Maraviroc—Vomiting—Mometasone—atopic dermatitis	6.05e-05	0.000458	CcSEcCtD
Maraviroc—Rash—Mometasone—atopic dermatitis	6e-05	0.000454	CcSEcCtD
Maraviroc—Dermatitis—Mometasone—atopic dermatitis	5.99e-05	0.000454	CcSEcCtD
Maraviroc—Abdominal pain—Tacrolimus—atopic dermatitis	5.98e-05	0.000453	CcSEcCtD
Maraviroc—Body temperature increased—Tacrolimus—atopic dermatitis	5.98e-05	0.000453	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NGF—atopic dermatitis	5.97e-05	0.000745	CbGpPWpGaD
Maraviroc—Headache—Mometasone—atopic dermatitis	5.96e-05	0.000451	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—atopic dermatitis	5.94e-05	0.000742	CbGpPWpGaD
Maraviroc—Erythema—Prednisolone—atopic dermatitis	5.92e-05	0.000449	CcSEcCtD
Maraviroc—Nausea—Fluocinolone Acetonide—atopic dermatitis	5.92e-05	0.000448	CcSEcCtD
Maraviroc—Eye disorder—Methylprednisolone—atopic dermatitis	5.84e-05	0.000442	CcSEcCtD
Maraviroc—Mental disorder—Hydrocortisone—atopic dermatitis	5.82e-05	0.000441	CcSEcCtD
Maraviroc—Cardiac disorder—Methylprednisolone—atopic dermatitis	5.8e-05	0.000439	CcSEcCtD
Maraviroc—Malnutrition—Hydrocortisone—atopic dermatitis	5.79e-05	0.000438	CcSEcCtD
Maraviroc—Erythema—Hydrocortisone—atopic dermatitis	5.79e-05	0.000438	CcSEcCtD
Maraviroc—Neutropenia—Prednisone—atopic dermatitis	5.78e-05	0.000438	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL2—atopic dermatitis	5.68e-05	0.000709	CbGpPWpGaD
Maraviroc—Angiopathy—Methylprednisolone—atopic dermatitis	5.67e-05	0.000429	CcSEcCtD
Maraviroc—Hallucination—Betamethasone—atopic dermatitis	5.65e-05	0.000428	CcSEcCtD
Maraviroc—Hallucination—Dexamethasone—atopic dermatitis	5.65e-05	0.000428	CcSEcCtD
Maraviroc—Nausea—Mometasone—atopic dermatitis	5.65e-05	0.000428	CcSEcCtD
Maraviroc—Mediastinal disorder—Methylprednisolone—atopic dermatitis	5.63e-05	0.000426	CcSEcCtD
Maraviroc—Hypersensitivity—Tacrolimus—atopic dermatitis	5.58e-05	0.000422	CcSEcCtD
Maraviroc—Depression—Prednisone—atopic dermatitis	5.49e-05	0.000416	CcSEcCtD
Maraviroc—Mental disorder—Methylprednisolone—atopic dermatitis	5.47e-05	0.000414	CcSEcCtD
Maraviroc—Erythema—Triamcinolone—atopic dermatitis	5.45e-05	0.000413	CcSEcCtD
Maraviroc—Erythema—Methylprednisolone—atopic dermatitis	5.44e-05	0.000412	CcSEcCtD
Maraviroc—Malnutrition—Methylprednisolone—atopic dermatitis	5.44e-05	0.000412	CcSEcCtD
Maraviroc—Asthenia—Tacrolimus—atopic dermatitis	5.43e-05	0.000411	CcSEcCtD
Maraviroc—Acute coronary syndrome—Prednisone—atopic dermatitis	5.43e-05	0.000411	CcSEcCtD
Maraviroc—Myocardial infarction—Prednisone—atopic dermatitis	5.4e-05	0.000409	CcSEcCtD
Maraviroc—Neuropathy peripheral—Prednisone—atopic dermatitis	5.4e-05	0.000409	CcSEcCtD
Maraviroc—Pruritus—Tacrolimus—atopic dermatitis	5.36e-05	0.000406	CcSEcCtD
Maraviroc—Syncope—Prednisolone—atopic dermatitis	5.31e-05	0.000402	CcSEcCtD
Maraviroc—Eye disorder—Betamethasone—atopic dermatitis	5.31e-05	0.000402	CcSEcCtD
Maraviroc—Eye disorder—Dexamethasone—atopic dermatitis	5.31e-05	0.000402	CcSEcCtD
Maraviroc—CCR5—Disease—CD4—atopic dermatitis	5.21e-05	0.00065	CbGpPWpGaD
Maraviroc—Loss of consciousness—Prednisolone—atopic dermatitis	5.21e-05	0.000394	CcSEcCtD
Maraviroc—Syncope—Hydrocortisone—atopic dermatitis	5.19e-05	0.000393	CcSEcCtD
Maraviroc—Diarrhoea—Tacrolimus—atopic dermatitis	5.18e-05	0.000392	CcSEcCtD
Maraviroc—Angiopathy—Betamethasone—atopic dermatitis	5.15e-05	0.00039	CcSEcCtD
Maraviroc—Angiopathy—Dexamethasone—atopic dermatitis	5.15e-05	0.00039	CcSEcCtD
Maraviroc—Convulsion—Prednisolone—atopic dermatitis	5.13e-05	0.000389	CcSEcCtD
Maraviroc—Loss of consciousness—Hydrocortisone—atopic dermatitis	5.09e-05	0.000385	CcSEcCtD
Maraviroc—Alopecia—Dexamethasone—atopic dermatitis	5.02e-05	0.00038	CcSEcCtD
Maraviroc—Alopecia—Betamethasone—atopic dermatitis	5.02e-05	0.00038	CcSEcCtD
Maraviroc—Convulsion—Hydrocortisone—atopic dermatitis	5.01e-05	0.00038	CcSEcCtD
Maraviroc—Dizziness—Tacrolimus—atopic dermatitis	5.01e-05	0.000379	CcSEcCtD
Maraviroc—Discomfort—Prednisolone—atopic dermatitis	4.98e-05	0.000377	CcSEcCtD
Maraviroc—Erythema—Dexamethasone—atopic dermatitis	4.94e-05	0.000374	CcSEcCtD
Maraviroc—Erythema—Betamethasone—atopic dermatitis	4.94e-05	0.000374	CcSEcCtD
Maraviroc—Myalgia—Hydrocortisone—atopic dermatitis	4.93e-05	0.000373	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NFKBIA—atopic dermatitis	4.92e-05	0.000615	CbGpPWpGaD
Maraviroc—Hallucination—Prednisone—atopic dermatitis	4.92e-05	0.000373	CcSEcCtD
Maraviroc—Anxiety—Hydrocortisone—atopic dermatitis	4.91e-05	0.000372	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.89e-05	0.00037	CcSEcCtD
Maraviroc—Syncope—Triamcinolone—atopic dermatitis	4.89e-05	0.00037	CcSEcCtD
Maraviroc—Syncope—Methylprednisolone—atopic dermatitis	4.88e-05	0.000369	CcSEcCtD
Maraviroc—Discomfort—Hydrocortisone—atopic dermatitis	4.87e-05	0.000369	CcSEcCtD
Maraviroc—Connective tissue disorder—Prednisone—atopic dermatitis	4.86e-05	0.000368	CcSEcCtD
Maraviroc—Oedema—Prednisolone—atopic dermatitis	4.84e-05	0.000366	CcSEcCtD
Maraviroc—Vomiting—Tacrolimus—atopic dermatitis	4.81e-05	0.000364	CcSEcCtD
Maraviroc—Loss of consciousness—Triamcinolone—atopic dermatitis	4.79e-05	0.000363	CcSEcCtD
Maraviroc—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.78e-05	0.000362	CcSEcCtD
Maraviroc—Rash—Tacrolimus—atopic dermatitis	4.77e-05	0.000361	CcSEcCtD
Maraviroc—Dermatitis—Tacrolimus—atopic dermatitis	4.77e-05	0.000361	CcSEcCtD
Maraviroc—Shock—Prednisolone—atopic dermatitis	4.76e-05	0.00036	CcSEcCtD
Maraviroc—Cough—Triamcinolone—atopic dermatitis	4.75e-05	0.00036	CcSEcCtD
Maraviroc—Headache—Tacrolimus—atopic dermatitis	4.74e-05	0.000359	CcSEcCtD
Maraviroc—Oedema—Hydrocortisone—atopic dermatitis	4.72e-05	0.000358	CcSEcCtD
Maraviroc—Convulsion—Triamcinolone—atopic dermatitis	4.72e-05	0.000357	CcSEcCtD
Maraviroc—Convulsion—Methylprednisolone—atopic dermatitis	4.71e-05	0.000357	CcSEcCtD
Maraviroc—Infection—Hydrocortisone—atopic dermatitis	4.69e-05	0.000355	CcSEcCtD
Maraviroc—Shock—Hydrocortisone—atopic dermatitis	4.65e-05	0.000352	CcSEcCtD
Maraviroc—Myalgia—Triamcinolone—atopic dermatitis	4.64e-05	0.000351	CcSEcCtD
Maraviroc—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.63e-05	0.000351	CcSEcCtD
Maraviroc—Myalgia—Methylprednisolone—atopic dermatitis	4.63e-05	0.00035	CcSEcCtD
Maraviroc—Eye disorder—Prednisone—atopic dermatitis	4.62e-05	0.00035	CcSEcCtD
Maraviroc—Anxiety—Methylprednisolone—atopic dermatitis	4.61e-05	0.000349	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.6e-05	0.000348	CcSEcCtD
Maraviroc—Skin disorder—Hydrocortisone—atopic dermatitis	4.59e-05	0.000347	CcSEcCtD
Maraviroc—Discomfort—Triamcinolone—atopic dermatitis	4.58e-05	0.000347	CcSEcCtD
Maraviroc—Discomfort—Methylprednisolone—atopic dermatitis	4.57e-05	0.000346	CcSEcCtD
Maraviroc—Anorexia—Hydrocortisone—atopic dermatitis	4.5e-05	0.000341	CcSEcCtD
Maraviroc—Nausea—Tacrolimus—atopic dermatitis	4.5e-05	0.00034	CcSEcCtD
Maraviroc—Angiopathy—Prednisone—atopic dermatitis	4.49e-05	0.00034	CcSEcCtD
Maraviroc—Oedema—Triamcinolone—atopic dermatitis	4.45e-05	0.000337	CcSEcCtD
Maraviroc—Syncope—Betamethasone—atopic dermatitis	4.43e-05	0.000336	CcSEcCtD
Maraviroc—Syncope—Dexamethasone—atopic dermatitis	4.43e-05	0.000336	CcSEcCtD
Maraviroc—Infection—Triamcinolone—atopic dermatitis	4.42e-05	0.000335	CcSEcCtD
Maraviroc—Infection—Methylprednisolone—atopic dermatitis	4.41e-05	0.000334	CcSEcCtD
Maraviroc—Shock—Triamcinolone—atopic dermatitis	4.37e-05	0.000331	CcSEcCtD
Maraviroc—Insomnia—Prednisolone—atopic dermatitis	4.37e-05	0.000331	CcSEcCtD
Maraviroc—Alopecia—Prednisone—atopic dermatitis	4.37e-05	0.000331	CcSEcCtD
Maraviroc—Shock—Methylprednisolone—atopic dermatitis	4.37e-05	0.000331	CcSEcCtD
Maraviroc—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.35e-05	0.000329	CcSEcCtD
Maraviroc—Loss of consciousness—Dexamethasone—atopic dermatitis	4.35e-05	0.000329	CcSEcCtD
Maraviroc—Loss of consciousness—Betamethasone—atopic dermatitis	4.35e-05	0.000329	CcSEcCtD
Maraviroc—Paraesthesia—Prednisolone—atopic dermatitis	4.34e-05	0.000329	CcSEcCtD
Maraviroc—Mental disorder—Prednisone—atopic dermatitis	4.33e-05	0.000328	CcSEcCtD
Maraviroc—Skin disorder—Methylprednisolone—atopic dermatitis	4.31e-05	0.000326	CcSEcCtD
Maraviroc—Erythema—Prednisone—atopic dermatitis	4.31e-05	0.000326	CcSEcCtD
Maraviroc—Malnutrition—Prednisone—atopic dermatitis	4.31e-05	0.000326	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.3e-05	0.000326	CcSEcCtD
Maraviroc—Convulsion—Dexamethasone—atopic dermatitis	4.28e-05	0.000324	CcSEcCtD
Maraviroc—Convulsion—Betamethasone—atopic dermatitis	4.28e-05	0.000324	CcSEcCtD
Maraviroc—Insomnia—Hydrocortisone—atopic dermatitis	4.27e-05	0.000323	CcSEcCtD
Maraviroc—Paraesthesia—Hydrocortisone—atopic dermatitis	4.24e-05	0.000321	CcSEcCtD
Maraviroc—Myalgia—Dexamethasone—atopic dermatitis	4.21e-05	0.000319	CcSEcCtD
Maraviroc—Myalgia—Betamethasone—atopic dermatitis	4.21e-05	0.000319	CcSEcCtD
Maraviroc—Anxiety—Dexamethasone—atopic dermatitis	4.19e-05	0.000318	CcSEcCtD
Maraviroc—Anxiety—Betamethasone—atopic dermatitis	4.19e-05	0.000318	CcSEcCtD
Maraviroc—Discomfort—Betamethasone—atopic dermatitis	4.16e-05	0.000315	CcSEcCtD
Maraviroc—Discomfort—Dexamethasone—atopic dermatitis	4.16e-05	0.000315	CcSEcCtD
Maraviroc—Pain—Prednisolone—atopic dermatitis	4.14e-05	0.000313	CcSEcCtD
Maraviroc—Decreased appetite—Hydrocortisone—atopic dermatitis	4.11e-05	0.000311	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	4.08e-05	0.000309	CcSEcCtD
Maraviroc—Fatigue—Hydrocortisone—atopic dermatitis	4.07e-05	0.000308	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	4.05e-05	0.000307	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	4.04e-05	0.000306	CcSEcCtD
Maraviroc—Pain—Hydrocortisone—atopic dermatitis	4.04e-05	0.000306	CcSEcCtD
Maraviroc—Oedema—Betamethasone—atopic dermatitis	4.03e-05	0.000306	CcSEcCtD
Maraviroc—Oedema—Dexamethasone—atopic dermatitis	4.03e-05	0.000306	CcSEcCtD
Maraviroc—Insomnia—Triamcinolone—atopic dermatitis	4.02e-05	0.000305	CcSEcCtD
Maraviroc—Insomnia—Methylprednisolone—atopic dermatitis	4.01e-05	0.000304	CcSEcCtD
Maraviroc—Infection—Betamethasone—atopic dermatitis	4.01e-05	0.000304	CcSEcCtD
Maraviroc—Infection—Dexamethasone—atopic dermatitis	4.01e-05	0.000304	CcSEcCtD
Maraviroc—Paraesthesia—Triamcinolone—atopic dermatitis	3.99e-05	0.000302	CcSEcCtD
Maraviroc—Paraesthesia—Methylprednisolone—atopic dermatitis	3.98e-05	0.000302	CcSEcCtD
Maraviroc—Anaemia—Prednisone—atopic dermatitis	3.98e-05	0.000301	CcSEcCtD
Maraviroc—Shock—Dexamethasone—atopic dermatitis	3.97e-05	0.000301	CcSEcCtD
Maraviroc—Shock—Betamethasone—atopic dermatitis	3.97e-05	0.000301	CcSEcCtD
Maraviroc—Nervous system disorder—Dexamethasone—atopic dermatitis	3.96e-05	0.0003	CcSEcCtD
Maraviroc—Nervous system disorder—Betamethasone—atopic dermatitis	3.96e-05	0.0003	CcSEcCtD
Maraviroc—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.86e-05	0.000292	CcSEcCtD
Maraviroc—Syncope—Prednisone—atopic dermatitis	3.86e-05	0.000292	CcSEcCtD
Maraviroc—Anorexia—Dexamethasone—atopic dermatitis	3.85e-05	0.000291	CcSEcCtD
Maraviroc—Anorexia—Betamethasone—atopic dermatitis	3.85e-05	0.000291	CcSEcCtD
Maraviroc—Fatigue—Triamcinolone—atopic dermatitis	3.83e-05	0.00029	CcSEcCtD
Maraviroc—Fatigue—Methylprednisolone—atopic dermatitis	3.83e-05	0.00029	CcSEcCtD
Maraviroc—Pain—Triamcinolone—atopic dermatitis	3.8e-05	0.000288	CcSEcCtD
Maraviroc—Loss of consciousness—Prednisone—atopic dermatitis	3.78e-05	0.000287	CcSEcCtD
Maraviroc—Abdominal pain—Hydrocortisone—atopic dermatitis	3.73e-05	0.000283	CcSEcCtD
Maraviroc—Body temperature increased—Hydrocortisone—atopic dermatitis	3.73e-05	0.000283	CcSEcCtD
Maraviroc—Convulsion—Prednisone—atopic dermatitis	3.73e-05	0.000282	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.68e-05	0.000278	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.68e-05	0.000278	CcSEcCtD
Maraviroc—Myalgia—Prednisone—atopic dermatitis	3.67e-05	0.000278	CcSEcCtD
Maraviroc—Anxiety—Prednisone—atopic dermatitis	3.65e-05	0.000277	CcSEcCtD
Maraviroc—Insomnia—Dexamethasone—atopic dermatitis	3.65e-05	0.000276	CcSEcCtD
Maraviroc—Insomnia—Betamethasone—atopic dermatitis	3.65e-05	0.000276	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.64e-05	0.000276	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.63e-05	0.000275	CcSEcCtD
Maraviroc—Paraesthesia—Dexamethasone—atopic dermatitis	3.62e-05	0.000274	CcSEcCtD
Maraviroc—Paraesthesia—Betamethasone—atopic dermatitis	3.62e-05	0.000274	CcSEcCtD
Maraviroc—Discomfort—Prednisone—atopic dermatitis	3.62e-05	0.000274	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisolone—atopic dermatitis	3.56e-05	0.00027	CcSEcCtD
Maraviroc—Body temperature increased—Triamcinolone—atopic dermatitis	3.52e-05	0.000266	CcSEcCtD
Maraviroc—Oedema—Prednisone—atopic dermatitis	3.51e-05	0.000266	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCL8—atopic dermatitis	3.51e-05	0.000438	CbGpPWpGaD
Maraviroc—Abdominal pain—Methylprednisolone—atopic dermatitis	3.51e-05	0.000266	CcSEcCtD
Maraviroc—Decreased appetite—Betamethasone—atopic dermatitis	3.51e-05	0.000266	CcSEcCtD
Maraviroc—Decreased appetite—Dexamethasone—atopic dermatitis	3.51e-05	0.000266	CcSEcCtD
Maraviroc—Infection—Prednisone—atopic dermatitis	3.49e-05	0.000264	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.48e-05	0.000264	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.48e-05	0.000264	CcSEcCtD
Maraviroc—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.48e-05	0.000263	CcSEcCtD
Maraviroc—Fatigue—Betamethasone—atopic dermatitis	3.48e-05	0.000263	CcSEcCtD
Maraviroc—Fatigue—Dexamethasone—atopic dermatitis	3.48e-05	0.000263	CcSEcCtD
Maraviroc—Shock—Prednisone—atopic dermatitis	3.46e-05	0.000262	CcSEcCtD
Maraviroc—Pain—Dexamethasone—atopic dermatitis	3.45e-05	0.000261	CcSEcCtD
Maraviroc—Pain—Betamethasone—atopic dermatitis	3.45e-05	0.000261	CcSEcCtD
Maraviroc—Nervous system disorder—Prednisone—atopic dermatitis	3.45e-05	0.000261	CcSEcCtD
Maraviroc—Skin disorder—Prednisone—atopic dermatitis	3.41e-05	0.000258	CcSEcCtD
Maraviroc—Asthenia—Hydrocortisone—atopic dermatitis	3.39e-05	0.000257	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL2—atopic dermatitis	3.36e-05	0.000419	CbGpPWpGaD
Maraviroc—Anorexia—Prednisone—atopic dermatitis	3.35e-05	0.000254	CcSEcCtD
Maraviroc—Pruritus—Hydrocortisone—atopic dermatitis	3.34e-05	0.000253	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6—atopic dermatitis	3.34e-05	0.000417	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.3e-05	0.00025	CcSEcCtD
Maraviroc—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.3e-05	0.00025	CcSEcCtD
Maraviroc—Hypersensitivity—Triamcinolone—atopic dermatitis	3.28e-05	0.000248	CcSEcCtD
Maraviroc—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.27e-05	0.000248	CcSEcCtD
Maraviroc—Diarrhoea—Hydrocortisone—atopic dermatitis	3.23e-05	0.000245	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.2e-05	0.000242	CcSEcCtD
Maraviroc—Dizziness—Prednisolone—atopic dermatitis	3.2e-05	0.000242	CcSEcCtD
Maraviroc—Asthenia—Triamcinolone—atopic dermatitis	3.19e-05	0.000242	CcSEcCtD
Maraviroc—Abdominal pain—Dexamethasone—atopic dermatitis	3.19e-05	0.000242	CcSEcCtD
Maraviroc—Body temperature increased—Betamethasone—atopic dermatitis	3.19e-05	0.000242	CcSEcCtD
Maraviroc—Abdominal pain—Betamethasone—atopic dermatitis	3.19e-05	0.000242	CcSEcCtD
Maraviroc—Body temperature increased—Dexamethasone—atopic dermatitis	3.19e-05	0.000242	CcSEcCtD
Maraviroc—Asthenia—Methylprednisolone—atopic dermatitis	3.18e-05	0.000241	CcSEcCtD
Maraviroc—Insomnia—Prednisone—atopic dermatitis	3.18e-05	0.000241	CcSEcCtD
Maraviroc—Paraesthesia—Prednisone—atopic dermatitis	3.16e-05	0.000239	CcSEcCtD
Maraviroc—Pruritus—Triamcinolone—atopic dermatitis	3.15e-05	0.000238	CcSEcCtD
Maraviroc—Pruritus—Methylprednisolone—atopic dermatitis	3.14e-05	0.000238	CcSEcCtD
Maraviroc—Dizziness—Hydrocortisone—atopic dermatitis	3.12e-05	0.000236	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MAPK8—atopic dermatitis	3.09e-05	0.000386	CbGpPWpGaD
Maraviroc—Decreased appetite—Prednisone—atopic dermatitis	3.05e-05	0.000231	CcSEcCtD
Maraviroc—Rash—Prednisolone—atopic dermatitis	3.05e-05	0.000231	CcSEcCtD
Maraviroc—Dermatitis—Prednisolone—atopic dermatitis	3.05e-05	0.000231	CcSEcCtD
Maraviroc—Diarrhoea—Methylprednisolone—atopic dermatitis	3.04e-05	0.00023	CcSEcCtD
Maraviroc—Fatigue—Prednisone—atopic dermatitis	3.03e-05	0.000229	CcSEcCtD
Maraviroc—Headache—Prednisolone—atopic dermatitis	3.03e-05	0.000229	CcSEcCtD
Maraviroc—Constipation—Prednisone—atopic dermatitis	3e-05	0.000228	CcSEcCtD
Maraviroc—Vomiting—Hydrocortisone—atopic dermatitis	3e-05	0.000227	CcSEcCtD
Maraviroc—Rash—Hydrocortisone—atopic dermatitis	2.98e-05	0.000225	CcSEcCtD
Maraviroc—Dermatitis—Hydrocortisone—atopic dermatitis	2.97e-05	0.000225	CcSEcCtD
Maraviroc—Headache—Hydrocortisone—atopic dermatitis	2.96e-05	0.000224	CcSEcCtD
Maraviroc—Dizziness—Triamcinolone—atopic dermatitis	2.94e-05	0.000223	CcSEcCtD
Maraviroc—Dizziness—Methylprednisolone—atopic dermatitis	2.93e-05	0.000222	CcSEcCtD
Maraviroc—Asthenia—Dexamethasone—atopic dermatitis	2.89e-05	0.000219	CcSEcCtD
Maraviroc—Asthenia—Betamethasone—atopic dermatitis	2.89e-05	0.000219	CcSEcCtD
Maraviroc—Gastrointestinal pain—Prednisone—atopic dermatitis	2.87e-05	0.000218	CcSEcCtD
Maraviroc—Nausea—Prednisolone—atopic dermatitis	2.87e-05	0.000217	CcSEcCtD
Maraviroc—Pruritus—Betamethasone—atopic dermatitis	2.85e-05	0.000216	CcSEcCtD
Maraviroc—Pruritus—Dexamethasone—atopic dermatitis	2.85e-05	0.000216	CcSEcCtD
Maraviroc—Vomiting—Triamcinolone—atopic dermatitis	2.83e-05	0.000214	CcSEcCtD
Maraviroc—Vomiting—Methylprednisolone—atopic dermatitis	2.82e-05	0.000214	CcSEcCtD
Maraviroc—CCR5—Disease—IL6—atopic dermatitis	2.82e-05	0.000352	CbGpPWpGaD
Maraviroc—Nausea—Hydrocortisone—atopic dermatitis	2.81e-05	0.000212	CcSEcCtD
Maraviroc—Rash—Triamcinolone—atopic dermatitis	2.8e-05	0.000212	CcSEcCtD
Maraviroc—Dermatitis—Triamcinolone—atopic dermatitis	2.8e-05	0.000212	CcSEcCtD
Maraviroc—Rash—Methylprednisolone—atopic dermatitis	2.8e-05	0.000212	CcSEcCtD
Maraviroc—Dermatitis—Methylprednisolone—atopic dermatitis	2.79e-05	0.000212	CcSEcCtD
Maraviroc—Headache—Triamcinolone—atopic dermatitis	2.79e-05	0.000211	CcSEcCtD
Maraviroc—Headache—Methylprednisolone—atopic dermatitis	2.78e-05	0.00021	CcSEcCtD
Maraviroc—Abdominal pain—Prednisone—atopic dermatitis	2.78e-05	0.00021	CcSEcCtD
Maraviroc—Body temperature increased—Prednisone—atopic dermatitis	2.78e-05	0.00021	CcSEcCtD
Maraviroc—Diarrhoea—Dexamethasone—atopic dermatitis	2.76e-05	0.000209	CcSEcCtD
Maraviroc—Diarrhoea—Betamethasone—atopic dermatitis	2.76e-05	0.000209	CcSEcCtD
Maraviroc—Dizziness—Betamethasone—atopic dermatitis	2.67e-05	0.000202	CcSEcCtD
Maraviroc—Dizziness—Dexamethasone—atopic dermatitis	2.67e-05	0.000202	CcSEcCtD
Maraviroc—Nausea—Triamcinolone—atopic dermatitis	2.64e-05	0.0002	CcSEcCtD
Maraviroc—Nausea—Methylprednisolone—atopic dermatitis	2.64e-05	0.0002	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisone—atopic dermatitis	2.59e-05	0.000196	CcSEcCtD
Maraviroc—Vomiting—Betamethasone—atopic dermatitis	2.57e-05	0.000194	CcSEcCtD
Maraviroc—Vomiting—Dexamethasone—atopic dermatitis	2.57e-05	0.000194	CcSEcCtD
Maraviroc—Rash—Dexamethasone—atopic dermatitis	2.54e-05	0.000193	CcSEcCtD
Maraviroc—Rash—Betamethasone—atopic dermatitis	2.54e-05	0.000193	CcSEcCtD
Maraviroc—Dermatitis—Dexamethasone—atopic dermatitis	2.54e-05	0.000192	CcSEcCtD
Maraviroc—Dermatitis—Betamethasone—atopic dermatitis	2.54e-05	0.000192	CcSEcCtD
Maraviroc—Headache—Betamethasone—atopic dermatitis	2.53e-05	0.000191	CcSEcCtD
Maraviroc—Headache—Dexamethasone—atopic dermatitis	2.53e-05	0.000191	CcSEcCtD
Maraviroc—Asthenia—Prednisone—atopic dermatitis	2.52e-05	0.000191	CcSEcCtD
Maraviroc—Pruritus—Prednisone—atopic dermatitis	2.49e-05	0.000188	CcSEcCtD
Maraviroc—Diarrhoea—Prednisone—atopic dermatitis	2.4e-05	0.000182	CcSEcCtD
Maraviroc—Nausea—Betamethasone—atopic dermatitis	2.4e-05	0.000181	CcSEcCtD
Maraviroc—Nausea—Dexamethasone—atopic dermatitis	2.4e-05	0.000181	CcSEcCtD
Maraviroc—Dizziness—Prednisone—atopic dermatitis	2.32e-05	0.000176	CcSEcCtD
Maraviroc—Vomiting—Prednisone—atopic dermatitis	2.23e-05	0.000169	CcSEcCtD
Maraviroc—Rash—Prednisone—atopic dermatitis	2.22e-05	0.000168	CcSEcCtD
Maraviroc—Dermatitis—Prednisone—atopic dermatitis	2.21e-05	0.000168	CcSEcCtD
Maraviroc—Headache—Prednisone—atopic dermatitis	2.2e-05	0.000167	CcSEcCtD
Maraviroc—Nausea—Prednisone—atopic dermatitis	2.09e-05	0.000158	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL6—atopic dermatitis	1.97e-05	0.000246	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.53e-05	0.000191	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.47e-05	0.000183	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.96e-06	6.2e-05	CbGpPWpGaD
